IVIG for Neuromuscular Disorders
In some immune-mediated disorders, the immune system can attack the peripheral nervous system, the central nervous system or the neuromuscular junctions (where nerves tell muscles what to do). MedRx Infusion dispenses intravenous immunoglobulin (IVIG) and other therapies for these conditions, delivers them with supplies at no charge, and can send a skilled nurse from an accredited nursing agency to administer them at home.
Connect with MedRx Infusion team todayPress Get Started to get in touch with our specialistsGet started
Share your contact information, and our specialists from the MedRx Infusion team will reach out to you to discuss home infusion and specialty pharmacy care. Only a contact name and phone number are required; additional clinical and insurance details help us begin the intake process sooner.
Reviewed by Tony Elias, PharmD, IgCP ·
What are neuromuscular disorders?
Neuromuscular disorders affect how nerve signals reach the muscle. In the immune-mediated disorders on this page, an autoimmune attack on the peripheral nerves or the neuromuscular junction causes weakness, and in some, numbness or tingling, most often in the limbs.
MedRx Infusion Clinical Pharmacy is a home infusion and specialty pharmacy serving patients in 44 states, the District of Columbia and Puerto Rico. Therapy starts with a referral from the prescriber's office.
Chronic inflammatory demyelinating polyneuropathy (CIDP)
CIDP is an immune-mediated neuropathy in which damage to myelin, the protective sheath of the nerves, causes progressive weakness of the arms and legs over months or years, often with numbness and tingling that begin in both hands and feet. It is usually chronic and often requires long-term treatment.
Evaluation by a neurologist typically includes a neurological examination, including reflexes, nerve conduction studies with electromyography (EMG), and blood and urine tests.
Treatment options include corticosteroids, plasmapheresis (plasma exchange) and immune globulin. Therapies FDA-approved for adults with CIDP and dispensed by MedRx:
- Intravenous immune globulin: Gammagard Liquid, Gammaked, Gamunex-C, Panzyga and Privigen
- Subcutaneous immune globulin: Hizentra and HyQvia, as maintenance therapy to prevent relapse, started after intravenous immune globulin. See SCIG at home.
- Subcutaneous FcRn blocker: Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase)
Guillain-Barré syndrome (GBS)
GBS is an acute immune-mediated polyneuropathy. Weakness and abnormal sensations typically begin in the feet and legs and ascend to the arms and upper body over days to weeks. Like CIDP, it results from damage to myelin. Severe cases can cause respiratory compromise and paralysis requiring hospital care, including mechanical ventilation.
Plasmapheresis or IVIG is usually started promptly after diagnosis. IVIG is not FDA-approved for GBS; its use in GBS is off-label.
Multifocal motor neuropathy (MMN)
MMN is a rare immune-mediated neuropathy that affects motor nerves only. It causes weakness without sensory loss, typically beginning in the hands and often asymmetric.
Gammagard Liquid, given intravenously, is FDA-approved as maintenance therapy for adults with MMN.
Myasthenia gravis (MG)
Myasthenia gravis is a chronic autoimmune disease in which antibodies against receptors at the neuromuscular junction impair signal transmission from nerve to muscle. It causes fatigable weakness of voluntary muscles: weakness that worsens with activity and improves with rest. The ocular, facial and bulbar muscles (those used for eye movement, chewing, speaking and swallowing) are most often affected; respiratory, neck and limb muscles can be involved.
FDA-approved for generalized MG and dispensed by MedRx:
- Vyvgart (efgartigimod alfa-fcab), an FcRn blocker, intravenous, and Vyvgart Hytrulo, subcutaneous, for adults
- Rystiggo (rozanolixizumab-noli), an FcRn blocker, subcutaneous infusion, for adults who are anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive
- Imaavy (nipocalimab-aahu), an FcRn blocker, intravenous, for patients 12 years and older who are AChR or MuSK antibody positive
- Soliris (eculizumab), a complement inhibitor, intravenous, for patients 6 years and older who are AChR antibody positive
- Ultomiris (ravulizumab-cwvz), a complement inhibitor, intravenous, for adults who are AChR antibody positive
- Zilbrysq (zilucoplan), a complement inhibitor, a subcutaneous injection the patient or a caregiver gives after training, for adults who are AChR antibody positive
- Uplizna (inebilizumab-cdon), an antibody against CD19 that lowers B cells, intravenous, for adults who are AChR or MuSK antibody positive
Soliris, Ultomiris and Zilbrysq are available only through FDA-required REMS programs, and MedRx is certified to dispense all three.
IVIG is not FDA-approved for MG; its use in MG is off-label.
Dermatomyositis, an inflammatory myopathy, is covered on the page on autoimmune skin diseases.
How home therapy works
- The prescriber's office sends a referral: for IVIG or SCIG, the Immunoglobulin Referral Form (PDF), with recent clinical notes and laboratory results, by fax, or a call.
- MedRx's intake team verifies insurance benefits and obtains prior authorization when the plan requires it.
- Medication and supplies are delivered to the patient's door at no charge. Next-day delivery is available; timing varies by location.
- A skilled, trusted and licensed nurse from an accredited nursing agency administers the infusion and monitors vital signs and adverse reactions; for SCIG, the nurse trains the patient or caregiver.
- A MedRx pharmacist is available 24 hours a day, 7 days a week. MedRx's pharmacy team includes Ig Certified Pharmacists (IgCP), who hold a specialty certification in immune globulin therapy.
MedRx dispenses both on-label and off-label prescriptions written by the treating physician, who determines the therapy. See IVIG at home for more on home IVIG.
Insurance and cost
Health plans commonly require prior authorization for these therapies. MedRx's intake team verifies coverage and works with the prescriber's office on the documentation before the first delivery. Coverage of off-label use varies by plan.
Where out-of-pocket costs are a barrier, MedRx helps patients find and apply for copay assistance, grants and other financial aid. The manufacturers of these medicines also run patient support programs, named on each medication page.
Key facts
- Organization
- MedRx Infusion Clinical Pharmacy
- What we do
- A home infusion pharmacy and specialty pharmacy, with infusion nurses who visit patients at home and a pharmacist on call 24 hours a day, 7 days a week.
- Where
- Pharmacy at 417 N Oak St, Inglewood, CA 90302. Licensed in 44 states, the District of Columbia and Puerto Rico. See every place we serve
- Accreditation
- URAC (Specialty Pharmacy) and ACHC (Accreditation Commission for Health Care).
- Phone, 24 hours
- (844) 671-2600
- Fax
- (844) 671-2601
Accurate as of
Questions about neuromuscular disorders
01What is the difference between CIDP and GBS?
Both are immune-mediated demyelinating neuropathies. GBS is acute, progressing over days to weeks, and can require hospital care. CIDP progresses over months or years and is usually chronic.
02Which IVIG products are FDA-approved for CIDP?
Gammagard Liquid, Gammaked, Gamunex-C, Panzyga and Privigen are FDA-approved for adults with CIDP, given intravenously. MedRx dispenses all five.
03Can CIDP be treated with subcutaneous therapy?
Hizentra and HyQvia, subcutaneous immune globulins, are FDA-approved for adults with CIDP as maintenance therapy to prevent relapse, started after intravenous immune globulin. HyQvia is given with recombinant human hyaluronidase, an enzyme that helps the immune globulin spread under the skin. Vyvgart Hytrulo, given subcutaneously, is also approved for CIDP. The prescriber determines which is appropriate.
04Can IVIG for CIDP be given at home?
Yes, when the prescriber orders it and determines that home therapy is appropriate. MedRx delivers the medication and supplies, and a skilled nurse from an accredited nursing agency administers the infusion.
05Does MedRx coordinate IVIG therapy for CIDP?
Yes. MedRx Infusion is a specialty pharmacy that dispenses IVIG for CIDP, obtains the prior authorizations health plans require, delivers the medication, and coordinates with the prescriber and the infusion nurse.
06What are the signs and symptoms of myasthenia gravis?
In myasthenia gravis, the immune system attacks the neuromuscular junction, where nerves send signals to the muscles. Typical signs are ptosis (drooping eyelids), diplopia (double vision), difficulty chewing, swallowing or speaking, and weakness of the neck, arms and legs that makes moving difficult. The weakness usually worsens with activity and improves with rest.
07Is IVIG FDA-approved for myasthenia gravis?
No. IVIG is not FDA-approved for MG, so its use in MG is off-label. Medicines approved for generalized MG include the FcRn blockers Vyvgart (efgartigimod alfa-fcab), Rystiggo (rozanolixizumab-noli) and Imaavy (nipocalimab-aahu), the complement inhibitors Soliris (eculizumab), Ultomiris (ravulizumab-cwvz) and Zilbrysq (zilucoplan), and Uplizna (inebilizumab-cdon). MedRx dispenses all seven.
08Does insurance cover IVIG for CIDP?
Coverage depends on the plan and the product; many plans require prior authorization. MedRx's intake team verifies benefits before the first delivery and helps patients look for copay assistance.
Medications we fill
- Immune globulin: Gamunex-C, Gammagard Liquid, Privigen, Panzyga, Hizentra, HyQvia and Octagam.
- Other medicines for myasthenia gravis: Vyvgart, Rystiggo, Imaavy, Soliris, Ultomiris, Zilbrysq and Uplizna.
Each has its own page: what it is approved for, how it is given, and how to start. See every medication we fill.
Read more about home infusion nursing, biologic infusions at home, neurology specialty medications and CIDP treatment at home.
Send a referral
Intake handles benefits investigation, prior authorization and scheduling.
Send a referralFax
(844) 671-2601
Send a completed referral form
